These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38892451)

  • 1. Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity.
    Lőrincz H; Csiha S; Ratku B; Somodi S; Sztanek F; Paragh G; Harangi M
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-Dependent Associations between Serum Betatrophin Levels and Lipoprotein Subfractions in Diabetic and Nondiabetic Obese Patients.
    Lőrincz H; Csiha S; Ratku B; Somodi S; Sztanek F; Seres I; Paragh G; Harangi M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients.
    Szentpéteri A; Lőrincz H; Somodi S; Varga VE; Paragh G; Seres I; Paragh G; Harangi M
    Lipids Health Dis; 2018 Mar; 17(1):39. PubMed ID: 29506551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects.
    Lőrincz H; Katkó M; Harangi M; Somodi S; Gaál K; Fülöp P; Paragh G; Seres I
    Clin Endocrinol (Oxf); 2014 Sep; 81(3):370-7. PubMed ID: 24303851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness.
    El-Asrar MA; Andrawes NG; Ismail EA; Salem SM
    Vasc Med; 2015 Dec; 20(6):509-17. PubMed ID: 26091968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Lipoprotein Subfractions in 920 Patients With and Without Type 2 Diabetes.
    Zhao X; Zhang HW; Zhang Y; Li S; Xu RX; Sun J; Zhu CG; Wu NQ; Gao Y; Guo YL; Liu G; Dong Q; Li JJ
    Heart Lung Circ; 2017 Mar; 26(3):211-218. PubMed ID: 28027866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Circulating Oxidized LDL and Conventional Biomarkers of Cardiovascular Disease in a Cross-Sectional Study of the Navajo Population.
    Harmon ME; Campen MJ; Miller C; Shuey C; Cajero M; Lucas S; Pacheco B; Erdei E; Ramone S; Nez T; Lewis J
    PLoS One; 2016; 11(3):e0143102. PubMed ID: 26938991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?
    Osei K; Rhinesmith S; Gaillard T; Schuster D
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4596-601. PubMed ID: 14557428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Organokine Regulation in Non-Diabetic Obese Subjects: Halfway to the Cardiometabolic Danger Zone.
    Lőrincz H; Ratku B; Csiha S; Seres I; Szabó Z; Paragh G; Harangi M; Somodi S
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM.
    Reaven PD; Herold DA; Barnett J; Edelman S
    Diabetes Care; 1995 Jun; 18(6):807-16. PubMed ID: 7555507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of L-citrulline supplementation on glucose homeostasis, lipid profile, and some inflammatory factors in overweight and obese patients with type 2 diabetes: A double-blind randomized placebo-controlled trial.
    Azizi S; Mahdavi R; Mobasseri M; Aliasgharzadeh S; Abbaszadeh F; Ebrahimi-Mameghani M
    Phytother Res; 2021 Jun; 35(6):3157-3166. PubMed ID: 33876875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between markers of metabolic control and inflammation on severity of periodontal disease in patients with diabetes mellitus.
    Lim LP; Tay FB; Sum CF; Thai AC
    J Clin Periodontol; 2007 Feb; 34(2):118-23. PubMed ID: 17309586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity.
    Seshadri P; Iqbal N; Stern L; Williams M; Chicano KL; Daily DA; McGrory J; Gracely EJ; Rader DJ; Samaha FF
    Am J Med; 2004 Sep; 117(6):398-405. PubMed ID: 15380496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet - the RESOLVE trial.
    Dutheil F; Walther G; Chapier R; Mnatzaganian G; Lesourd B; Naughton G; Verney J; Fogli A; Sapin V; Duclos M; Vinet A; Obert P; Courteix D; Lac G
    Lipids Health Dis; 2014 Jul; 13():112. PubMed ID: 25015177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory markers and haptoglobin polymorphism in Saudi with non-insulin-dependent diabetes mellitus.
    Mohieldein A; Alzohairy M; Hasan M; Khan AA
    Glob J Health Sci; 2012 Nov; 5(1):135-42. PubMed ID: 23283045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.
    Abu-Farha M; Abubaker J; Al-Khairi I; Cherian P; Noronha F; Hu FB; Behbehani K; Elkum N
    Sci Rep; 2015 Jun; 5():10949. PubMed ID: 26077345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
    Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
    BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control?
    Patti L; Di Marino L; Maffettone A; Romano G; Annuzzi G; Riccardi G; Rivellese AA
    Diabetologia; 1995 Dec; 38(12):1419-24. PubMed ID: 8786015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.